510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K940142Substantially Equivalent

Glycated Protein Controls

Trinity Biotech (Primus Corporation dba Trinity Biotech), Kansas City MO / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K940142 is the FDA 510(k) clearance record for GLYCATED PROTEIN CONTROLS, a class I device, cleared for Primus Corp. on under FDA product code JJX (Single (Specified) Analyte Controls (Assayed And Unassayed)). FDA records list 16 510(k) clearances for Trinity Biotech (Primus Corporation dba Trinity Biotech), from to . As of , FDA records show no recalls naming K940142.

Clearance record

Decision date
Received
(105 days to decision)
Product code
JJX Single (Specified) Analyte Controls (Assayed And Unassayed)
Regulation
21 CFR 862.1660
Device class
Class I
Review panel
Clinical Chemistry
Applicant
Primus Corp. P.O. Box 22599, Kansas City MO
510(k) summary
Statement
Third party review
No

Clearances, product code JJX

Trailing 12 months

FDA records hold no clearances under product code JJX in the trailing twelve months.

FDA records show no clearances under product code JJX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code JJX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260